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Abstract 
 
The enhancer of rudimentary, e(r), gene encodes a small 
highly conserved protein, enhancer of rudimentary homolog 
(ERH), which has been shown to have a regulatory function 
in cell division, Notch signaling, and cancer progression.  
Human and Drosophila ERH, both 104 amino acids in length, 
are 76% identical and 84% similar.  The high sequence 
identity translates into nearly identical tertiary structures.  
Previous studies on the expression of the human and 
Drosophila e(r) genes reveal that the two genes are similarly 
regulated.  Data in the present study using an e(r)-eGFP 
reporter gene confirm these results, showing a high 
expression of the reporter in the ovaries, testes, and brain. The 
high structural and regulatory conservation of e(r) and ERH 
argue that human and Drosophila ERH may be biochemically 
and functionally equivalent.  To test this hypothesis, a 
chimeric transgene containing the Drosophila e(r) non-coding 
regions and the human e(r) coding region was constructed and 
used to establish transgenic Drosophila stocks.  This 
transgene can rescue all of the mutant phenotypes of an e(r) 
deletion, and Drosophila stocks in which the fly ERH has 
been replaced with the human ERH are fully healthy and 
viable.  These studies demonstrate that the human and 
Drosophila ERH are functionally equivalent, suggesting that 
studies on the activity of the human ERH can be done in 
Drosophila, where a multitude of genetic and developmental 
tools are available. 
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1.  Introduction 
 
 Since its discovery (1, 2), the 
enhancer of rudimentary gene, e(r), has been 
studied with respect to a role in mitosis, cell 
proliferation, and cancer. The e(r) gene was 
first shown to be expressed at high levels in 
oogenesis and in mitotic cells in the 
Drosophila embryo (2, 3, 4).  The expression 
pattern in the embryo is very similar to that 
of cyclin E (5) and correlates with cells that 
are undergoing DNA synthesis (6).  These 
similarities suggest a role for e(r) in the cell 
cycle and DNA replication.  This association 
with cell proliferation and DNA synthesis 
was first suggested genetically, when e(r) 
was identified as a positive regulator of 
rudimentary, r, the gene that codes for the 
first three enzymes in pyrimidine 
biosynthesis (2, 7).  The human homologue 
of r, CAD, is highly expressed in dividing 
cells (8, 9, 10).  Likewise, human e(r) is 
expressed at high levels in dividing cells 
(11) and has been shown to regulate the 
splicing of the pre-mRNA of CENP-E, a 
mitotic-motor-protein gene, indicating an 
important mitotic function (12).   
 The high expression of e(r) in 
dividing cells has led to the possibility that it 
may have a role in cancer.  This appears to 
be the case.  Human e(r) is expressed at high 
levels in cancerous tissue vs. normal tissue 
(11).   In particular, e(r) expression 
increases with the tumorigenic progression 
of human breast cancer and ovarian cancer 
cells, which has led to the hypothesis that 
ERH expression may be diagnostic for 
human cancer progression (11).  It also 
presents the intriguing possibility that high 
levels of ERH are necessary for tumor 
progression.  The necessity for e(r) 
expression in cancer has been examined 
with RNAi approaches.   In mRNA 
knockdown experiments with shRNA, e(r) 
was identified as a gene whose expression 
was necessary for the proliferation of 
pancreatic, breast, and ovarian cancer cell 
lines (13).  Similarly, e(r) mRNA 
knockdown decreased the viability of certain 
colorectal cancer cells with activated RAS 
mutations (12).  This study also showed that 
lower ERH expression correlated with 
increased survival of patients with tumors 
carrying activated RAS mutations.  Together 
these studies reveal that e(r) activity is 
necessary for the proliferation of certain 
types of cancers. 
 Besides the conserved expression in 
dividing cells, other patterns of the 
expression of e(r) may be conserved.  E(r) is 
expressed at high levels in developing 
ovaries in Drosophila (3).  In humans, e(r) is 
also expressed at high levels in ovaries as 
well as testes (11).   Similarly, in the mouse, 
Mus musculus, a microarray analysis of 
genes expressed in the developing 
embryonic ovaries and testes showed that 
among transcripts e(r) ranked in the 97th 
percentile for expression in the ovary and 
the testes (14, 15).  Thus e(r) is being 
expressed at high levels in the ovaries in 
three distantly related taxa, and in the testes 
in humans and mice.     
 The protein encoded by e(r) has been 
named ERH, enhancer of rudimentary 
homolog.  It is a small highly conserved 
protein (2, 16, 17).  The Drosophila 
melanogaster ERH is 76% identical to the 
vertebrate ERH, 49% identical to the 
nematode ERH, and 40% identical to the 
Arabidopsis ERH.  A high sequence 
conservation is seen within the vertebrates, 
with the human and mouse protein being 
identical and differing from the zebrafish 
protein by a single conservative amino acid 
change (valine to isoleucine) (17).   
The similarities in the expression of 
the human and Drosophila e(r) genes and 
the high conservation in the primary 
structure of the ERH, suggest that ERH may 
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be biochemically and functionally 
equivalent in both species.  In this paper we 
examine this hypothesis by first taking a 
closer look at the structure of the two 
proteins, second extending the comparison 
of the expression patterns, and finally using 
a human e(r) transgene to show that the 
human ERH can functionally replace the 
Drosophila ERH.  These data reveal the 
functional equivalence of the two proteins, 
and support the proposal that certain aspects 
of the human ERH activity and its regulation 
can be examined using the Drosophila 
model system.  
 
2.  Evolutionary conservation between the 
human and Drosophila ERH 
 
 The human and Drosophila ERH are 
both 104 amino acids in length and share a 
76% identity and an 83% similarity (16, 17). 
A closer pairwise comparison along the 
length of the 104 amino acids shows other 
striking similarities.  The positions of key 
groups of amino acids - hydrophobic amino 
acids, acidic amino acids, basic amino acids, 
and prolines are highly conserved between 
the two proteins (Fig. 1 a-d).  These 
similarities in the primary structures lead to 
the prediction that the human and 
Drosophila proteins fold into very similar 
tertiary structures. The mouse and human 
ERH (They are identical.) have been 
synthesized in bacteria, purified, and their 
tertiary structure determined (18, 19).  The 
protein folds into a single domain with a β-
sheet formed by four β-strands (Fig. 1g).  
This flat surface is involved in the 
dimerization of the protein.  There are also 
three α-helices that contribute to the 
globular shape of the protein.  The web 
server SWISS-MODEL (20) was used to 
generate a predicted tertiary structure of the 
Drosophila ERH.  SWISS-MODEL uses an 
evolutionary modeling approach, know-
ledge of protein structure, and solved 
tertiary structures as references, to predict 
unknown structures.  As was expected from 
the conserved features of the primary 
structures, the predicted structure of the 
Drosophila ERH (Fig. 1h) is highly similar 
to the solved human structure (Fig. 1g).  
Both have the β-sheet involved in protein 
binding and the three α-helices. 
 The high similarities in the primary 
and tertiary structures of the human and 
Drosophila ERH suggest that the two 
proteins have similar biochemical functions 
and regulatory features.  Two other 
conserved features between these two 
proteins support this proposal.  First, two 
casein kinase II sites that have been shown 
to be important in the regulation of the 
Drosophila ERH (21) are also present in the 
human ERH (Fig. 1e).  This suggests that 
the human ERH may be regulated by casein 
kinase II in a similar manner to the 
Drosophila ERH.  Second, seven amino 
acids (5I, 7L, 17R, 19Y, 21D, 70L, 79Y) 
were shown to be highly important in the 
dimerization of the human ERH (18).  Six 
out of the seven of these sights are strictly 
conserved between human and Drosophila 
(Fig. 1f).  The one amino acid that is not 
conserved is a leucine to methionine 
substitution, which is a conservative 
substitution and could be serving the same 
function in the Drosophila ERH. 
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(g)      (h) 
 
 
 
 
 
 
 
Figure 1.  Comparison of the structures of human and Drosophila ERH.  Various 
comparisons of the primary and tertiary structures of the human and Drosophila ERH 
are highlighted and show a high evolutionary conservation.  (a) Positions of the 
hydrophobic amino acids (I, F, L, M, V).  (b) Positions of the acidic amino acids (D, 
E).  (c) Positions of the basic amino acids (H, K, R).  (d) Position of the prolines (P).  
(e) Positions of two CKII phosphorylation sites, shown to be important in the 
regulation of ERH in Drosophila (21).  (f)  Positions of seven amino acids (5I, 7L, 
17R, 19Y, 21D, 70L, 79Y) shown to be highly important in the dimerization of the 
human ERH (18).  (g) Solved tertiary structure of the human ERH (R).  (h) Predicted 
model for the tertiary structure of the Drosophila ERH. 
 
3.  Construction of transgenes used in this 
study 
 
 In order to examine the tissue 
distribution of e(r) and to test the functional 
equivalence of the human and Drosophila 
ERH, chimeric transgenes were constructed 
which consisted of the transcriptional and 
translational regulatory regions of the 
Drosophila e(r) gene and the protein coding 
regions of either the enhanced green 
fluorescent protein gene (eGFP) or the 
human e(r) gene.  All of the transcriptional 
and translational regulatory regions of the 
Drosophila e(r) are contained within a 3.0-
kb PvuII-SalI fragment (Fig. 2a).  The 
transgene that consists of this fragment is 
referred to as ER1 in this paper, and is used 
as a positive control for normal e(r) activity.  
This transgene rescues the null mutant 
phenotypes of two e(r) deletions, e(r)27-1 and 
e(r)37-6 (3; Tables 2-5).  The regions of the 
e(r) gene that are deleted in these two 
mutations are shown in Fig. 2a.  Both of 
these deletions remove the upstream region 
contained in ER1 and the start of 
transcription.  In the case of e(r)27-1, 43% of 
the coding region is also deleted.  
 The construction of the chimeric 
transgenes, started with the construction of 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
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an “empty” e(r) gene (Fig. 2b).  This gene 
contains all of the non-coding DNA within 
the PvuII-SalI fragment, but is lacking the 
coding region for ERH.  In its place is a 
unique NcoI restriction-enzyme site 
(CCATGG).  This site was chosen because 
using it will retain the start codon (ATG) 
and the Drosophila translation signal 
(CACC) that immediately precedes the start 
codon.  In practice, coding regions can be 
synthesized or amplified with PCR to 
contain an NcoI-compatible site at the 5’end 
and at the 3’ end, immediately following the 
stop codon.  The PCR approach was used to 
amplify the human e(r) coding region and 
the eGFP coding region using appropriate 5’ 
and 3’ primers (Table 1) in the creation of 
the two chimeric transgenes (Fig. 2 d & e).  
 The significance of this approach to 
produce these e(r) transgenes, is that the 
inserted coding region will be regulated 
identically to the normal e(r) gene.  For the 
eGFP transgene, this means that GFP can be 
used to examine the normal spatial 
distribution of ERH.  For the human e(r) 
transgene, we can examine the ability of the 
human ERH to rescue the mutant e(r) 
phenotypes, when it is expressed at normal 
physiological levels, instead of over-
produced levels.  In this way we can more 
accurately compare the functionality of the 
human and Drosophila ERH. 
 
  (a) 
 
 
 
 
 
 
 
 
 
  (b) 
  (c) 
  (d) 
  (e) 
 
Figure 2.  The wild-type Drosophila e(r) gene and the transgenes used in this 
project. (a) The 6.1-kb SalI, genomic region containing the e(r) gene is drawn as a 
horizontal line.  The two transcripts of e(r) are indicated below the line.  The extent 
of the two e(r) deletions is shown above the line.  The 3.0-kb PvuII-SalI fragment 
that was used to create the wild-type e(r) transgene, ER1, is shown below the 
transcripts.  (b) The “empty” e(r) gene used in the construction of the human e(r) 
transgene and the eGFP transgene.  (c) Drosophila transgene, ER1.  (d) Hs-ER, the 
human e(r) transgene.  (e) e(r)-eGFP, the eGFP reporter gene.  A = AflII, E = 
EcoRV, N = NcoI, P = PvuII, and S = SalI. 
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           Table 1.  Primers used to amplify the coding regions to replace the Drosophila e(r)  
coding  region 
 
Primer Sequence 5’ to 3’ 
Human e(r) 5’ ACGACATGTCTCACACCATTTTGCT 
Human e(r) 3’ ATCCCATGGTTATTTCCCAGCCTGTTGGGC 
eGFP 5’ ACACCATGGTGAGCAAGGGCG 
eGFP 3’ ATCCCATGGTTACTTGTACAGCTCGTCCA 
 
In the 5’ primers, the start codon, ATG, is underlined.  Human e(r) 5’ contains a PciI 
site, ACATGT, necessary for retaining the second codon, TCT.  eGFP 5’ contains an 
NcoI site, CCATGG, for retaining the second codon, GTG.  In the 3’ primers, the 
stop codon (reverse complement), TTA, is underlined.  The human e(r) cDNA and 
the eGFP cDNA were used as templates in the PCR. 
          
 
 
4.  e(r)-eGFP expression patterns 
 
 Drosophila stocks containing the 
e(r)-eGFP reporter gene, with the eGFP 
coding region under the control of the e(r) 
transcription and translation regulatory 
regions (Fig. 2e), were used to determine the 
expression patterns of the e(r) gene.  Three 
developmental stages were examined: pre-
blastoderm embryos, 3rd instar larvae, and 
adults. 
 Previous studies showed a high 
expression of e(r) in adult ovaries and in the 
blastoderm embryos (3), so we expected to 
see GFP expression in these tissues.  As 
expected there is high expression in pre-
blastoderm embryos (Fig 3 a & b).  This 
expression is the result of maternal 
expression of e(r)-eGFP and the deposition 
of the GFP mRNA and protein into the 
developing oocyte.  While GFP is 
distributed throughout the early embryo, 
there is a higher expression at the anterior 
and posterior poles.  This is polar 
localization can be seen in both pictures, but 
is more distinct when an embryo is 
photographed at a reduced exposure (Fig. 
3b).  While the cause of this localization is 
under investigation, we believe that it is the 
result of the localization of the e(r)-eGFP 
mRNA in the developing oocyte.  This type 
of localization is common in Drosophila 
oocytes.  Examples are the anterior 
localization of the bicoid mRNA (22) and 
the posterior localization of the oskar 
mRNA (23).  If the e(r)-eGFP mRNA is 
being localized to the poles of the oocyte, 
then that indicates that there are mRNA 
localization signals within the e(r) mRNA. 
 Expression of GFP in adult flies was 
first examined in intact individuals.  Both 
the adult female (Fig. 3c) and male (Fig. 3d) 
showed high GFP expression in the head 
and in the abdomen.  The main organ in the 
head is the brain, and the main organs in the 
abdomen are the ovaries in females and the 
testes in males.  The abdomens were 
dissected and as expected, high expression 
was seen in the ovaries (Fig. 3e) and the 
testes (Fig. 3f).  In the ovaries, expression 
appears to be higher in the early egg 
chambers to the right in the figure and lower 
in the more mature egg chambers to the left.  
This is consistent with the localization of 
e(r) mRNA which is present in the nurse cell 
of the developing egg chambers, and 
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deposited into the maturing oocyte (3).  In 
the testes we see highest expression in the 
primary spermatocytes.  The most apical 
region of the adult testis contains the 
spermatogonial cells that produce the 
primary spermatocytes via mitotic divisions.  
Adjacent to this region contains the 
developing primary spermatocytes, which 
will enter meiosis (24).  This apical region 
has low GFP expression, but the adjacent 
region corresponding to developing primary 
spermatocytes has high GFP expression 
(Fig. 3f).  Interestingly, studies in mice 
testes show that ERH is also localized to the 
developing spermatocytes (25). 
 Testes development begins in the 
larval stages, and by the 3rd instar larval 
stage they are easily visible with the 
stereomicroscope through the body wall as 
large spheres, and are used to distinguish 
male and female larvae.  GFP expression in 
whole male 3rd instar larvae can clearly be 
seen in the developing testes (Fig. 3g).  
Testes removed from the larvae show 
highest GFP expression in the region 
corresponding to primary spermatocytes 
(Fig. 3h).  This is in agreement with the GFP 
expression in the adult testis (Fig. 3f). 
 Ovary development in female 3rd 
instar larvae is minimal compared to testis 
development in male 3rd instar larvae, so the 
ovaries are not visible with a normal 
stereomicroscope.  However, a small focus 
of GFP expression can be seen in female 3rd 
instar larvae in the region where the ovaries 
should be present (Fig. 3i). 
 
 
               (a)                                   (b) 
 
 
 
 
               (c)                             (d)                            (e)                           (f) 
 
 
 
 
 
 
               (g)                                   (h)                                  (i) 
 
 
 
 
 
 
Figure 3.  Localization of GFP fluorescence from e(r)-eGFP.  (a) Pre-blastoderm 
embryo.  Expression is throughout the embryo with higher expression at the poles.  
(b) Lower exposure of a pre-blastoderm embryo.  Higher expression at the poles can 
clearly be seen.  For both embryos, anterior is to the left, posterior to the right, dorsal 
is on the top, and ventral is on the bottom.  (c) Adult female.  (d) Adult male.  In 
both adults the highest fluorescence is seen in the abdomens and the heads.  For the 
heads, the compound eyes serve as lenses for fluorescence from the interior.  (e) 
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Ovary from an adult female.  Development of the egg chambers is from right to left 
with the mature oocytes to the left.  Highest fluorescence is seen in the early egg 
chambers which are primarily composed of nurse cells that will eventually deposit 
their contents into the oocyte.   (f) Testis from an adult male.  Apical tip is at the 
lower right, and spermatogenesis progresses from the apical tip to the end of the 
coiled end of the testis.  (g) Male 3rd instar larva.  The two, highly fluorescing 
spheres inside the larva are the testes.  (h) Testis from 3rd instar.  The region of high 
fluorescence corresponds to the primary spermatocytes.  This is in agreement with 
GFP expression in the adult testis (f).  (i) Female 3rd instar larva.  The ovaries are not 
nearly as developed as the corresponding testes; however, a fluorescent spot in the 
location of the developing ovary can be seen in females.  It is indicated with an 
arrow.  GFP fluorescence was imaged using a Zeiss Discovery V8 fluorescent 
dissecting microscope with a GFP filter. 
 
 
 Expression of e(r) in the adult 
Drosophila brain had not been examined 
previously, so it was of interest to examine 
e(r)-eGFP expression in isolated brains.  In 
this localization study an antibody to GFP 
and a confocal microscope were used 
instead of GFP fluorescence and a dissecting 
microscope.  Expression appears to be 
ubiquitous in the brain and restricted 
primarily to the cell bodies of the nerve cells 
(Fig 4a).  Regions of the brain that show 
lower GFP expression are the synaptic 
regions, as shown by the antibody staining 
to Bruchpilot (26) a protein localized to 
synaptic regions of the brain (Fig 4b).  This 
high expression in the adult brain is 
consistent with the high expression of ERH 
in the embryonic and 3rd instar larval brain 
and CNS (4).  Thus, as with ovaries and 
testes, we see a high expression in the brain 
throughout the development of the fly.   
 It should be noted that in human and 
mouse, e(r) is also expressed in the brain. In 
human, northern blots and dot blots showed 
e(r) mRNA in the brain (11, 27).  In the 
mouse microarray analysis showed that of 
the transcripts expressed in the brain, e(r) 
ranked in the 91st percentile (15). 
 
                 (a)                                       (b)                                     (c) 
 
 
 
 
 
 
 
 
Figure 4.  GFP localization in the brain of the adult fly.  The images show antibody 
localization to the brain.  The view is from the front of the fly.  The compound eyes 
on the left and right have been removed.  (a) GFP antibody localization.  GFP can be 
seen throughout the brain, with most of the localization being in the cell bodies of 
the neurons.  (b) Bruchpilot antibody localization (mouse nc82 monoclonal 
antibody).  Bruchpilot localizes to synaptic junctions and thus identifies regions 
containing the axons of neurons.  These regions coincide with the regions of lower 
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GFP staining.  (c) Superimposed GFP and Bruchpilot localization. The brains were 
imaged at 630x magnification using a Zeiss LSM 700 confocal microscope. 
 
5.  Testing the functionality of the human 
ERH in Drosophila 
 
 The evolutionary conservation of the 
structures of the human and Drosophila 
ERH (Fig. 1) and the conserved aspects of 
the expression of the gene (Fig. 3 & 4), 
strongly suggest that the two proteins are 
functionally equivalent.  This possibility is 
supported by the fact that in human cells, the 
Drosophila ERH expressed from a 
Drosophila e(r) transgene, is nuclearly 
localized like its human counterpart (28).  
This means that Drosophila ERH must 
successfully interact with the nuclear 
localization system of the human ERH.  In 
addition, the human and Drosophila ERH, 
both have RPS3 as a binding partner, and 
the Drosophila ERH can successfully 
interact with the human RPS3 in a yeast 
two-hybrid assay (28).  
 To test the functional equivalence of 
the human and Drosophila ERH, we 
constructed a human e(r) transgene that 
contains all of the non-coding regulatory 
regions of the Drosophila e(r) gene with the 
coding region of the human e(r) gene (Fig. 
2d).  The significance of this construction is 
that it ensures that the human e(r) coding 
region will be expressed in an identical 
pattern to the normal Drosophila e(r) gene, 
and importantly at normal levels, rather than 
over-expressed levels.  This chimeric e(r) 
gene was used to transform Drosophila 
melanogaster, and stocks containing an 
autosomal transgene were established.  
These transgenic stocks were used to test the 
ability of the human ERH to rescue the 
mutant phenotypes of an e(r) null mutation.  
Four different mutant phenotypes were 
utilized: 1) lethality of the e(r)27-1 rhd1 
double mutant, 2) lethality of the e(r)37-6 Nnd-
p
 double mutant, 3) low fecundity of e(r)27-1 
females, and 4) low viability of the e(r)27-1 
mutant.  The two e(r) alleles used in this 
study are both deletions and act as e(r) null 
alleles (3, Fig. 2a).  For the rescue 
experiments, crosses were performed to 
produce flies which were missing the 
Drosophila e(r) gene, but which had the 
human e(r) transgene.  As a positive control 
in all of the tests, stocks containing ER1, the 
Drosophila melanogaster e(r) transgene, 
were used to show rescue by the Drosophila 
melanogaster e(r) gene. 
 
6.  The human e(r) transgene rescues the 
lethality of the e(r)27-1 rhd1 double mutant. 
 
 The original e(r) mutant allele, 
e(r)p1, was isolated as an enhancer of the 
mutant wing phenotype of a rudimentary 
allele, rhd1 (1, 2).  It turned out e(r)p1 was a 
leaky e(r) mutation, and that the 
combination of an e(r) null with rhd1 has a 
very low viability (Table 2).  Both e(r) and r 
are X-linked genes so the lethality of the 
e(r)27-1 rhd1 double mutant can be assessed 
by the absence of the hemizygous males. 
Rescue of the lethality is seen by the 
presence of the double mutant males with 
the transgene.  Heterozygous females from 
the crosses are used as a control for normal 
viability.  As can be seen in Table 2, two 
different human e(r) transgenes can rescue 
the double mutant lethality.  As a control, 
the equivalent Drosophila melanogaster e(r) 
transgene, ER1, also rescues the double 
mutant lethality.  The Male/Female ration 
shows that all three transgenes show good 
rescue.  The lower than wild-type viability 
of these males is caused by the rhd1 
mutation.  The rescue in these experiments 
show that the human ERH can interact 
successfully with rudimentary and 
pyrimidine metabolism in Drosophila.
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Table 2.  Rescue of lethality of e(r)27-1 rhd1 
 
Genotype Tested e(r)27-1 rhd1/+ Females e(r)27-1 rhd1 Males  Male/Female 
e(r)27-1 rhd1 642 0 0.00 
e(r)27-1 rhd1; ER1 165 37 0.22 
e(r)27-1 rhd1; Hs-ER 4F 297 110 0.37 
e(r)27-1 rhd1; Hs-ER 1F 196 61 0.31 
 
 
7.  The human e(r) transgene rescues the 
lethality of the Nnd-p e(r)37-6 double 
mutant. 
 
 The weak Notch allele, Nnd-p, was 
isolated in a lethal interaction with a weak 
e(r) allele, e(r)p2 (4).  In the background of 
e(r)+, Nnd-p mutants show good viability, but 
the double mutant combinations with leaky 
or null e(r) alleles are lethal (4).  Since both 
N and e(r) are X-linked genes, lethality of 
the double mutants is seen as the absence of 
hemizygous males (Table 3).  Heterozygous 
females are used as a control.  Full viability 
of the hemizygous males would produce 
equal numbers of males and females.  The 
Nnd-p e(r)37-6 double mutant is lethal.  As a 
negative control the e(r)-eGFP transgene 
(Fig. 2e) used in the expression studies (Fig. 
3 & 4) did not rescue the lethality (Table 3).  
Two different stocks carrying the Hs-ER 
transgene were used in this study, and in 
both cases the lethality of Nnd-p e(r)37-6 was 
rescued.  The extent of the rescue as seen by 
the Male/Female rescue was similar to that 
seen with the Drosophila melanogaster e(r) 
transgene, ER1 (Table 3).  The lower than 
wild-type viability of the transgenic males is 
caused by the Nndp mutation.  The rescue in 
these experiments show that, in the 
interaction with the Notch signaling 
pathway in Drosophila, the human ERH 
functions normally. 
 
 
Table 3.  Rescue of lethality of Nnd-p e(r)37-6 
 
Genotype Tested Nndp e(r)37-6/+ 
Female  
Nndp e(r)37-6 
Male 
Progeny 
Male/Female  
Nnd-p e(r)37-6 656 0 0.00 
Nnd-p e(r)37-6; e(r)-eGFP 389 0 0.00 
Nnd-p e(r)37-6; ER1 148 38 0.26 
Nnd-p e(r)37-6; Hs-ER 4F 293 66 0.22 
Nnd-p e(r)37-6; Hs-ER 4M 98 33 0.34 
 
 
8.  The human e(r) transgene rescues the 
low fecundity of e(r)27-1 females. 
 
 There is high expression e(r) in the 
developing ovaries (3, Fig. 3e).  Thus it is 
not unexpected that e(r) null females 
produce very few offspring.  To test the 
ability of the human e(r) transgene to rescue 
the low fecundity of the e(r)27-1 females, 
stocks were constructed that were 
homozygous for both e(r)27-1 and an 
autosomal insertion of the human e(r) 
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transgene or the Drosophila e(r) transgene, 
ER1.  Ten females of each stock were 
crossed to ten wild-type males, and allowed 
to lay eggs for ten days.  The total number 
of adult progeny produced from these 
crosses was used as a measure of fecundity.  
Both human e(r) transgenes rescue the low 
fecundity at levels comparable to that of the 
Drosophila e(r) transgene (Table 4).  These 
data indicate that the human ERH can 
perform the function in Drosophila that are 
necessary to produce normal female 
fecundity.  This requires activity in the 
normal development of the ovaries.
 
Table 4.  Rescue of low fecundity of e(r) null females 
 
Genotype of females Total Progeny 
e(r)27‑1 21 
e(r)27‑1; ER1 620 
e(r)27‑1; Hs-ER 1F 1027 
e(r)27‑1; Hs-ER 1M 748 
 
 
9.  The human e(r) transgene rescues the 
low viability of e(r)27-1 mutants. 
 
 While null mutants of e(r) are not 
lethal, they have a low a low viability (3).  
This low viability is probably the result of 
the lack of e(r) activity in a number of 
different tissues.  To test the ability of the 
human e(r) transgene to rescue this low 
viability, crosses were set up to produce 
e(r)27-1 hemizygous males with or without 
the e(r) transgene.  If the e(r) transgene does 
not rescue the low viability, then these two 
groups of e(r)27-1 males should be present in 
equal amounts and in low numbers.  If the 
e(r) transgene rescues the low viability, then 
the transgene containing males should be 
significantly greater in number than the 
males without the transgene.  As a control 
for wild-type viability the e(r)27-1/+, 
transgene containing females from the 
crosses were counted.  If the e(r)27-1, 
transgene containing males have wild-type 
viability, then their numbers should 
approximate the number of these females.  
The human e(r) transgene rescued the low 
viability of the e(r)27-1 males (Table 5).  The 
number of transgene containing males was 
much greater than those of the e(r)27-1 males 
without the transgene, and were close to the 
numbers of the control females.  As a 
positive control, the Drosophila e(r) 
transgene also showed rescue of the low 
viability of e(r)27-1 males, at a similar level 
to the rescue seen by the human e(r) 
transgene.  In both cases the number of 
transgene containing males was about six 
times that of the males without the 
transgene.
 
Table 5.  Rescue of the low viability of e(r)27-1 mutants 
 
Genotype Tested e(r)27-1/+; 
transgene Females 
e(r)27-1; 
transgene  
Males  
e(r)27-1  Males  males with 
transgene/ 
males without 
transgene 
e(r)27-1; ER1 160 194 32 6.06 
e(r)27-1 ; Hs-ER 1F 278 245 41 5.98 
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10.  Conclusions and Discussion 
 
 The different e(r) mutant phenotypes 
reveal the roles of e(r) in different aspects of 
Drosophila development and physiology and 
in different biochemical and signaling 
pathways.   The rescue of all of these mutant 
phenotypes by the human e(r) transgene, at 
levels comparable to the Drosophila e(r) 
transgene, indicates that the human ERH can 
functionally replace the Drosophila ERH 
throughout the development of the fruit fly.  
In fact, we now maintain viable and healthy 
stocks of Drosophila melanogaster in which 
the Drosophila e(r) has been deleted and 
replaced with the human e(r) transgene used 
in this study.  This means that we have not 
been able to identify any e(r) loss-of-
function phenotypes that cannot be rescued 
by the human ERH. Thus, the human and 
Drosophila ERH are functionally equivalent 
within the fruit fly, Drosophila 
melanogaster. 
 There are other data that argue that 
the human and Drosophila ERH are 
performing similar functions.  In 
Drosophila, its initial isolation as a regulator 
or pyrimidine biosynthesis and its 
expression in dividing cells pointed to a role 
in DNA synthesis and mitosis (1, 2).  This 
has also been noted in humans, where e(r) 
expression is associated with dividing cells, 
specifically cancer cells (11), indicating a 
possible function in cancer progression.  
Consistent with this proposal is the evidence 
that down-regulation of e(r) by RNAi 
inhibits the progression of certain cancers 
(12, 13), and low e(r) expression correlates 
with higher survival among patients with 
certain cancers (12).  Understanding the 
activity and regulation of ERH will be 
important in defining its role in cancer.  
Given the functional equivalence of the 
human and Drosophila ERH, the various 
e(r) mutant phenotypes, and the assays for 
wild-type ERH activity in Drosophila, the 
Drosophila melanogaster system will be 
useful in dissecting human ERH activity. 
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